Tuesday 7th September, 2010 | 4:50 pm
Home
|
Sitemap
|
Contact us
Stock Quote
 |
Press Releases
 |
Financial Reports
 |
Electronic IR Package
 |
Site Search:
Stock Quote
Press releases
Financial Reports
Analysts
Webcast
Q4 Announcement
Home
GHRH Phase II Final Results
Fentanyl TAIFUN Phase IIb extension arm results
Q1 Earnings Announcement
Q2 Earnings Announcement
Akela Pharma, name change and corporate update
Media
Electronic IR Package
Contact
Analyst Coverage
Firm
Analyst
Coutry
Jennings Capital
Shameze Rampertab
Canada
Desjardins Securities
Maher Yaghi
Canada
Paradigm Capital
Claude Camire
Canada
General Research
Georg Hochwimmer
Germany
Home
::
Our Company
::
Investor Relations
::
Products and Technologies
::
Business Units
::
Contact us
::
Site map
::
FAQ
Copyright 2007 © Akela Pharma